| Citation: |
HUANG Yan, REN Hongbo, LIU Ying. STAT3-RARa-positive Acute Promyelocytic Leukemia: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 1035-1038. DOI: 10.3971/j.issn.1000-8578.2023.23.0168
|
Competing interests: The authors declare that they have no competing interests.
| [1] |
Yao L, Wen L, Wang N, et al. Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t (15; 17)(q22;q12)/PML-RARA[J]. Blood, 2018, 131(8): 935-939. doi: 10.1182/blood-2017-09-807370
|
| [2] |
徐欣欣, 吕振慧, 刘凯奇, 等. 伴STAT3-RARα阳性急性早幼粒细胞白血病一例报告并文献复习[J]. 中华血液学杂志, 2019, 40(8): 688-690. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS201709024.htm
Xu X, Lyu Z, Liu K, et al. Acute promyelocytic leukemia with STAT3-RARαfusion gene: a case report and literature review[J]. Zhonghua Xue Ye Xue Za Zhi, 2019, 40(8): 688-690. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS201709024.htm
|
| [3] |
Verhoeven Y, Tilborghs S, Jacobs J. The potential and controversy of targeting STAT family members in cancer[J]. Semin Cancer Biol, 2020, 60: 41-56. doi: 10.1016/j.semcancer.2019.10.002
|
| [4] |
Jin W. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition[J]. Cells, 2020, 9(1): 217. doi: 10.3390/cells9010217
|
| [5] |
Kim BH, Yi EH, Ye SK. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment[J]. Arch Pharm Res, 2016, 39(8): 1085-1099. doi: 10.1007/s12272-016-0795-8
|
| [6] |
Liquori A, Ibañez M, Sargas C, et al. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene[J]. Cancers (Basel), 2020, 12(3): 624. doi: 10.3390/cancers12030624
|
| [7] |
Jimenez JJ, Chale RS, Abad AC, et al. Acute promyelocytic leukemia (APL): a review of the literature[J]. Oncotarget, 2020, 11(11): 992-1003 doi: 10.18632/oncotarget.27513
|
| [8] |
陈一瑞. 急性早幼粒细胞白血病中维甲酸受体α融合基因的研究进展[J]. 国际输血及血液学杂志, 2013, 36 (4): 425-428. doi: 10.3760/cma.j.issn.1673-419X.2013.04.012
Chen YR. Research progress of retinoic acid receptor alpha fusion gene in acute promyelocytic leukemia[J]. Guo Ji Su Xue Ji Xue Ye Xue Za Zhi, 2013, 36(4): 425-428. doi: 10.3760/cma.j.issn.1673-419X.2013.04.012
|
| [9] |
Katsumura KR, Mehta C, Hewitt KJ, et al. Human leukemia mutations corrupt but do not abrogate GATA-2 function[J]. Proc Natl Acad Sci U S A. 2018, 115(43): E10109-E10118.
|
| [10] |
Leubolt G, Redondo Monte E, Greif PA. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies[J]. IUBMB Life, 2020, 72(1): 151-158. doi: 10.1002/iub.2204
|
| [11] |
Katerndahl CDS, Rogers ORS, Day RB, et al. Tumor suppressor function of Gata2 in acute promyelocytic leukemia[J]. Blood, 2021, 138(13): 1148-1161. doi: 10.1182/blood.2021011758
|
| [12] |
Lu W, Jia D, An S, et al. Calf Spleen Extractive Injection protects mice against cyclophosphamide-induced hematopoietic injury through G-CSF-mediated JAK2/STAT3signaling[J]. Sci Rep, 2017, 7(1): 8402.
|
Figures(1) / Tables(1)
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: